💡 What You Need to Know Right Away
- Methylfolate augmentation improves antidepressant response by 25% compared to antidepressants alone (RR: 1.25, 95% CI 1.08-1.46).[Evidence: A][1]
- Adjunct folate therapy improves depression response rates by 36% and remission rates by 39% versus SSRI/SNRI alone.[Evidence: A][3]
- Folate supplementation reduces stroke risk by 10% and overall cardiovascular disease by 4%.[Evidence: A][4]
- Methylfolate combination therapy reduces homocysteine by 30% and LDL cholesterol by 7.5% in MTHFR polymorphism patients.[Evidence: B][5]
If you have been researching folate supplements, you may feel overwhelmed by the different forms available. Methylfolate, folic acid, folinic acid. Which one actually works? And more importantly, which one works for you?
Methylfolate (also known as L-5-MTHF or levomefolic acid) is the bioactive form of vitamin B9. Unlike synthetic folic acid, your body can use methylfolate immediately without requiring conversion. This matters especially if you have genetic variations affecting folate metabolism. In this comprehensive guide, you will learn exactly how methylfolate benefits your mental health, cardiovascular system, and overall wellness, all backed by clinical research from 16 peer-reviewed studies.
❓ Quick Answers
What is methylfolate?
Methylfolate (L-5-methyltetrahydrofolate or 5-MTHF) is the biologically active form of vitamin B9 (folate). Unlike synthetic folic acid, methylfolate requires no enzymatic conversion and is immediately usable by the body. It plays essential roles in DNA synthesis, neurotransmitter production, and homocysteine metabolism.[Evidence: D][13]
How does methylfolate work?
Methylfolate works by donating methyl groups in the methylation cycle. It converts homocysteine to methionine and supports production of neurotransmitters including serotonin, dopamine, and norepinephrine. Methylfolate bypasses the MTHFR enzyme bottleneck that affects 30-70% of enzyme activity in people with genetic variants.[Evidence: D][6]
What foods contain methylfolate?
Natural folate sources include dark leafy greens (spinach, kale), asparagus, Brussels sprouts, legumes, and liver. However, dietary folate must be converted to methylfolate through multiple enzymatic steps. Fermentation and sprouting can increase folate bioavailability in foods. For reliable methylfolate intake, supplementation may be preferred.
What are the benefits of methylfolate?
Clinical research shows methylfolate benefits include improved antidepressant response (36% higher response rates), reduced stroke risk (10% reduction), lower homocysteine levels (30% reduction in MTHFR carriers), and neural tube defect prevention (aRR 0.54).[Evidence: A][3][4][5][11]
How much methylfolate should I take?
Dosage varies by purpose. For depression augmentation, studies used 15 mg daily. For homocysteine reduction in MTHFR carriers, 1.5 mg daily was effective. For diabetic neuropathy support, 3 mg daily showed benefits. Always consult a healthcare provider before starting supplementation.[Evidence: A][1][Evidence: B][5]
Is methylfolate safe?
Methylfolate has a favorable safety profile. No tolerable upper intake level (UL) has been established specifically for 5-MTHF. Studies report no evidence of serious adverse effects at therapeutic doses. However, individuals with bipolar disorder should use caution as methylfolate may trigger mood episodes. Consult your healthcare provider before use.[Evidence: A][11]
Is methylfolate better than folic acid?
Methylfolate offers advantages over folic acid. It is absorbed at a wider pH range, bypasses the MTHFR enzyme bottleneck, and avoids unmetabolized folic acid (UMFA) accumulation. Studies show serum folate increases more rapidly with 5-MTHF than folic acid (P<0.0001). The EFSA confirms 5-MTHF is more bioavailable than folic acid at doses ≥400 μg/day.[Evidence: B][15][Evidence: D][14]
Can methylfolate help with depression?
Yes, clinical evidence supports methylfolate for depression. A meta-analysis of 9 studies (N=6,707) found adjunctive L-methylfolate improved antidepressant response with a relative risk of 1.25 (95% CI 1.08-1.46, p=0.004). Systematic reviews also show levomefolic acid improved outcomes in major depressive disorder as adjunct therapy.[Evidence: A][1][8]
🔬 How Does Methylfolate Work?
Think of methylfolate as the master key in your body's chemical messaging system. Just as a key unlocks a door, methylfolate "unlocks" hundreds of biochemical reactions by donating methyl groups. These tiny chemical packages activate genes, build neurotransmitters, and keep your cardiovascular system running smoothly.
At its core, methylfolate participates in the methylation cycle. This is your body's recycling plant for the amino acid homocysteine. When functioning properly, methylfolate converts homocysteine into methionine, which then becomes S-adenosylmethionine (SAMe). The methylation cycle affects over 200 bodily processes, from DNA repair to mood regulation.
However, approximately 30-70% of people with the MTHFR C677T genetic variant have reduced enzyme activity.[Evidence: D][6] This means their bodies struggle to convert synthetic folic acid into usable methylfolate. Taking methylfolate directly bypasses this bottleneck entirely.[Evidence: D][13]
Mental Health Mechanism
Methylfolate supports production of monoamine neurotransmitters including serotonin, dopamine, and norepinephrine. These chemicals regulate mood, motivation, and emotional well-being. In the brain, methylfolate is the only form of folate that crosses the blood-brain barrier. Systematic reviews confirm levomefolic acid improved outcomes in major depressive disorder, schizophrenia, autism, ADHD, and bipolar disorder as adjunctive therapy.[Evidence: A][8]
Cardiovascular Mechanism
Elevated homocysteine is a cardiovascular risk factor. Methylfolate helps convert homocysteine to methionine, reducing circulating levels. In MTHFR polymorphism patients, methylfolate combination therapy reduced homocysteine by 30%, with homozygous carriers achieving 48.3% reduction.[Evidence: B][5] Additional studies confirm both l-methylfolate and folinic acid reduce homocysteine significantly at 3 months, with 677TT genotype showing greater reduction.[Evidence: B][7]
Meta-analyses demonstrate that folate supplementation reduces stroke risk by 10-15% (RR=0.85, 95% CI: 0.76-0.96) and overall cardiovascular disease by 4%, with greater benefits in populations with lower baseline folate status.[Evidence: A][4][12]
Neurological Support
Folate plays a role in peripheral nerve health. A systematic review of 12 studies (N=3,015) found folate supplementation for peripheral neuropathy achieved symptomatic pain reduction of approximately 3 points, 87.5% symptom resolution, and 97% improvement in epidermal nerve fiber density (ENFD).[Evidence: A][10]
In diabetic peripheral neuropathy specifically, L-methylfolate combined with methylcobalamin and pyridoxal-5-phosphate achieved 35% reduction in NTSS-6 symptom scores at 12 weeks and 32% pain reduction.[Evidence: C][9]
Pregnancy and Neural Development
Folate is critical for neural tube closure during early fetal development. The US Preventive Services Task Force systematic review confirms folic acid supplementation reduces neural tube defects with an adjusted relative risk of 0.54 before pregnancy and 0.62 during pregnancy, with no evidence of harms.[Evidence: A][11]
📊 Dosage and How to Use
Methylfolate dosing varies considerably based on the intended purpose. Unlike folic acid, which has an established upper intake level of 1,000 μg/day for synthetic forms, methylfolate does not have a specific tolerable upper limit established by regulatory agencies. The table below summarizes evidence-based dosing from clinical studies.
| Purpose/Condition | Dosage | Duration | Evidence |
|---|---|---|---|
| Depression augmentation (with SSRIs) | 15 mg/day | 30-60 days | [A][1] |
| MDD with obesity/inflammation markers | 15 mg/day | Per clinician guidance | [D][2] |
| Homocysteine reduction (MTHFR polymorphism) | 1.5 mg/day (with B12 + P5P) | 180 days | [B][5] |
| Diabetic peripheral neuropathy | 3 mg/day (with B12 + P5P) | 90+ days | [C][9] |
Important Dosing Considerations
Start Low: If you are new to methylfolate supplementation, consider starting at a lower dose (400-800 mcg) and gradually increasing. Some individuals experience temporary side effects when beginning methylation support.
Depression Dosing: For depression augmentation, 15 mg/day has been the most studied dose. A 2023 review confirmed 15 mg/day is most effective, with better outcomes observed in patients with BMI ≥30 kg/m² and elevated inflammatory markers.[Evidence: D][2]
Combination Therapy: For homocysteine reduction, studies used methylfolate in combination with methylcobalamin (vitamin B12) and pyridoxal-5-phosphate (active vitamin B6). The combination approach addresses multiple points in the methylation pathway.[Evidence: B][5]
Timing: Methylfolate can be taken with or without food. Some practitioners recommend morning dosing to avoid potential sleep interference, though this is based on clinical experience rather than controlled trials.
⚠️ Risks, Side Effects, and Warnings
Side Effects by Frequency
Specific side effect frequency data from controlled trials is limited in the available literature. Reported side effects from clinical experience include:
- Common (reported in clinical practice): Headache, gastrointestinal upset, irritability, sleep disturbances
- Uncommon: Anxiety, restlessness, overstimulation symptoms
- Rare but serious: Mood destabilization in bipolar disorder, allergic reactions
Note: The systematic reviews analyzed did not report standardized adverse event frequency data. Individual response varies. Monitor for adverse reactions and consult your healthcare provider if symptoms occur.
Drug Interactions
Potential drug interactions include:
- Anticonvulsants (phenytoin, carbamazepine, valproate): May reduce folate levels; conversely, high-dose folate may affect anticonvulsant metabolism. Monitor seizure control and drug levels.
- Methotrexate: Methotrexate is a folate antagonist. Supplementation timing and approach requires medical supervision.
- SSRIs/SNRIs: Methylfolate is used as adjunctive therapy with these medications. No negative interactions reported; in fact, combination shows enhanced efficacy.[Evidence: A][1]
Contraindications
- Known allergy to folate supplements
- Undiagnosed anemia (rule out B12 deficiency first)
- Unstable bipolar disorder (use with caution and medical supervision)
When to Stop and Seek Medical Care
- Signs of allergic reaction (rash, difficulty breathing, swelling)
- Significant mood changes, especially manic symptoms
- Worsening of underlying condition
- Severe gastrointestinal symptoms that persist
🥗 Practical Ways to Use Methylfolate
How to Use This in Your Daily Life
Scenario 1: Depression Augmentation
- Dose: 15 mg daily[1]
- Duration: 30-60 days initially, ongoing as directed by prescriber[1]
- Population: Adults with major depressive disorder on SSRIs/SNRIs
- Timing: Morning with or without food
- What to track: Mood symptoms, energy levels, sleep quality
- Expected results: 25% improved antidepressant response (RR: 1.25)[1]; 36% improved response rates vs. antidepressant alone[3]
Scenario 2: MTHFR Polymorphism Support
- Dose: 1.5 mg methylfolate daily (with 1 mg B12 + 25 mg P5P)[5]
- Duration: 180 days in the clinical trial[5]
- Population: Adults 40-75 with confirmed MTHFR/MTR/MTRR polymorphisms
- Timing: With meals to enhance absorption
- What to track: Homocysteine levels (blood test), energy, cardiovascular markers
- Expected results: 30% homocysteine reduction; 7.5% LDL-C reduction; 48.3% reduction in homozygous carriers[5]
Scenario 3: Diabetic Neuropathy Support
- Dose: 3 mg methylfolate daily (with 2 mg methylcobalamin + 35 mg P5P)[9]
- Duration: 90+ days[9]
- Population: Adults with type 2 diabetes and peripheral neuropathy symptoms
- Timing: With meals
- What to track: Numbness, tingling, burning sensations, pain levels
- Expected results: 35% reduction in neuropathy symptom scores; 32% pain reduction[9]
Practical Integration
Take methylfolate at the same time each day to establish a routine. Store in a cool, dry place away from direct sunlight and moisture. Most methylfolate supplements are stable at room temperature but check product label for specific storage instructions.
Common Mistakes to Avoid
- Starting too high: Some individuals are sensitive to methylation support. Studies used therapeutic doses, but starting lower and titrating up may reduce initial side effects.
- Inconsistent dosing: Studies used daily dosing[1][5]. Sporadic use may not achieve the same benefits seen in controlled trials.
- Ignoring B12 status: Methylfolate works in conjunction with vitamin B12. Supplementing folate without adequate B12 can mask deficiency.
- Expecting immediate results: Depression augmentation trials ran 30-60 days. Homocysteine reduction studies ran 180 days. Allow adequate time for effects.
⚖️ Methylfolate vs. Folic Acid
Understanding the difference between methylfolate and folic acid is crucial for choosing the right supplement. Folic acid is the synthetic form found in most fortified foods and inexpensive supplements. Methylfolate (5-MTHF) is the bioactive form your body actually uses.
| Feature | Methylfolate (5-MTHF) | Folic Acid |
|---|---|---|
| Bioavailability | Immediately bioavailable; 2.0× conversion factor at ≥400 μg/day[14] | Requires enzymatic conversion through DHFR and MTHFR |
| MTHFR Compatibility | Bypasses MTHFR enzyme bottleneck[13] | Impaired conversion in 30-70% of people with C677T variant[6] |
| Absorption pH Range | Absorbed at wider pH range[13] | Optimal at specific pH |
| Unmetabolized Form | No UMFA accumulation; no UMFA exposure[15] | Can accumulate as unmetabolized folic acid (UMFA) |
| Serum Folate Response | Serum folate increased more rapidly (P<0.0001)[15] | Slower increase in serum folate |
| Cost | Higher cost per dose | Lower cost, widely available |
| Best For | MTHFR variants, depression augmentation, individuals seeking bioactive form | General population fortification, those without conversion issues |
A systematic review of bioavailability studies confirmed that studies finding significant differences showed 5-MTHF more effective at increasing folate levels compared to folic acid.[Evidence: A][16]
The European Food Safety Authority (EFSA) established that at doses ≥400 μg/day, the dietary folate equivalent (DFE) conversion factor for 5-MTHF is 2.0, confirming methylfolate is more bioavailable than folic acid at therapeutic doses.[Evidence: D][14]
When to Choose Methylfolate
- You have confirmed or suspected MTHFR genetic variants
- You are using folate for depression augmentation (clinical studies used methylfolate)
- You want to avoid potential UMFA accumulation
- You have tried folic acid without noticeable benefit
When Folic Acid May Be Sufficient
- General health maintenance without genetic concerns
- Cost is a primary consideration
- Meeting basic RDA requirements in healthy individuals
What The Evidence Shows (And Doesn't Show)
What Research Suggests
- L-methylfolate augmentation improves antidepressant response by 25% (RR: 1.25, 95% CI 1.08-1.46, p=0.004) based on meta-analysis of 9 studies with 6,707 participants.[1]
- Adjunct folate therapy improves depression response rates by 36% and remission rates by 39% compared to SSRI/SNRI alone (6 RCTs).[3]
- Folate supplementation reduces stroke risk by 10-15% (RR=0.85, 95% CI: 0.76-0.96) based on meta-analysis of 45 RCTs with 96,962 participants.[12]
- Methylfolate combination therapy reduces homocysteine by 30% overall and 48.3% in homozygous MTHFR carriers (54-patient RCT over 180 days).[5]
- Folic acid supplementation reduces neural tube defects by 38-46% (aRR 0.54 before pregnancy, 0.62 during pregnancy) per USPSTF systematic review.[11]
What's NOT Yet Proven
- Optimal dosage not established: Depression studies used 15 mg/day; MTHFR studies used 1.5 mg/day; neuropathy studies used 3 mg/day. No comparative dosing trials exist.
- Long-term safety beyond 180 days: The longest RCT in the dataset was 180 days (Source 5). Effects and safety of multi-year supplementation require further study.
- Direct methylfolate vs. folic acid head-to-head trials for clinical outcomes: Most bioavailability comparisons measure serum folate, not disease-specific outcomes.
- Anxiety-specific evidence: While depression data is strong, no RCTs specifically targeted anxiety disorders with methylfolate.
- Pediatric populations: Available studies focused on adults. Children and adolescents were not primary populations in the reviewed studies.
Where Caution Is Needed
- Bipolar disorder: Methylfolate may trigger mood episodes. Systematic review notes folate use in bipolar as adjunct therapy requires careful monitoring.[8]
- B12 deficiency masking: High-dose folate can mask B12 deficiency symptoms while neurological damage progresses. Ensure adequate B12 status before high-dose folate supplementation.
- Individual variation: MTHFR C677T reduces enzyme activity by 30-70%.[6] Response to methylfolate varies based on genotype and other factors.
- Depression augmentation context: Benefits shown when methylfolate is added to existing antidepressant therapy, not as standalone treatment.[1]
Should YOU Try This?
Best suited for: Adults with major depressive disorder inadequately responding to SSRIs/SNRIs; individuals with confirmed MTHFR polymorphisms and elevated homocysteine; those seeking a bioactive folate form that bypasses conversion requirements.
Not recommended for: Individuals with unstable bipolar disorder; those with undiagnosed anemia (rule out B12 deficiency first); pregnant women should consult healthcare provider for appropriate form and dosing.
Realistic timeline: Depression augmentation trials showed benefits within 30-60 days.[1] Homocysteine reduction was significant at 3-6 months.[5][7] Neuropathy symptom improvement observed at 12 weeks.[9]
When to consult a professional: Before starting if you have bipolar disorder or history of mania; if taking anticonvulsants, methotrexate, or other medications; if pregnant or planning pregnancy; if symptoms worsen or new symptoms develop after starting supplementation.
Frequently Asked Questions
Who should take methylfolate?
Methylfolate may benefit several populations. Individuals with MTHFR genetic variants (affecting approximately 40% of the population) cannot efficiently convert folic acid to its active form. People with treatment-resistant depression may benefit from methylfolate augmentation, as meta-analyses show improved response rates.[1] Those with elevated homocysteine levels, especially MTHFR polymorphism carriers, saw 30% reductions with methylfolate combination therapy.[5] Pregnant women or those planning pregnancy should discuss folate supplementation with their healthcare provider, as adequate folate is essential for neural tube development. Always consult a healthcare professional before starting any supplement regimen.
What is the MTHFR gene mutation?
MTHFR (methylenetetrahydrofolate reductase) is an enzyme that converts folic acid to methylfolate. The C677T polymorphism is the most studied variant, reducing enzyme activity by 30-70% in affected individuals. This genetic variation is common, with studies suggesting approximately 40% of the population carries at least one variant allele. People with reduced MTHFR activity may have elevated homocysteine levels and impaired folate metabolism. For these individuals, taking methylfolate directly bypasses the enzymatic bottleneck, providing the bioactive form without requiring conversion. Genetic testing can identify MTHFR variants, though not everyone with the variant requires supplementation.
Is methylfolate safe during pregnancy?
Folate is essential during pregnancy for preventing neural tube defects. The USPSTF systematic review confirms folic acid supplementation reduces neural tube defects with an adjusted relative risk of 0.54 when taken before pregnancy and 0.62 during pregnancy, with no evidence of harms. While most studies used folic acid, methylfolate offers advantages for women with MTHFR variants. Pharmacokinetic research shows 5-MTHF enables faster repletion of folate stores compared to folic acid. Pregnant women should consult their healthcare provider for appropriate dosing, typically 400-800 mcg daily as part of prenatal care.
Does methylfolate lower homocysteine?
Yes, clinical evidence demonstrates methylfolate effectively lowers homocysteine. A randomized controlled trial in MTHFR polymorphism patients found methylfolate combination therapy (with methylcobalamin and pyridoxal-5-phosphate) reduced homocysteine by 30% overall, with homozygous carriers achieving 48.3% reduction. Another study confirmed both l-methylfolate and folinic acid significantly reduced homocysteine at 3 months, with the 677TT genotype showing greater reduction. Elevated homocysteine is associated with cardiovascular risk, making this reduction clinically meaningful for heart health.
Can you take too much methylfolate?
While no specific tolerable upper intake level (UL) has been established for methylfolate by regulatory agencies, taking excessive amounts is not recommended. The EFSA upper limit of 1,000 μg/day applies to folic acid forms due to concerns about masking B12 deficiency. High-dose methylfolate (15 mg/day) has been used safely in clinical depression trials under medical supervision. However, some individuals experience symptoms of 'overmethylation' including anxiety, irritability, and insomnia with high doses. Start with lower doses and increase gradually. Monitor for adverse effects and work with a healthcare provider when using therapeutic doses.
Does methylfolate help anxiety?
Direct evidence for methylfolate and anxiety specifically is limited in the reviewed literature. The systematic review examining folate in psychiatric disorders found levomefolic acid improved outcomes in major depressive disorder, schizophrenia, autism, ADHD, and bipolar disorder as adjunctive therapy. Since depression and anxiety often co-occur, and methylfolate supports neurotransmitter production including serotonin, some individuals with anxiety may benefit. However, it is important to note that some people report increased anxiety as a side effect of methylation support. Individual response varies, and clinical trials specifically targeting anxiety disorders with methylfolate are needed.
Can methylfolate cause mania?
This is an important safety consideration. Individuals with bipolar disorder may be at risk for mood destabilization when taking methylfolate. The systematic review on folate in psychiatric disorders noted levomefolic acid was used in bipolar disorder as adjunct therapy, but careful monitoring is essential. Methylfolate supports dopamine and norepinephrine synthesis, which could potentially trigger manic episodes in susceptible individuals. Anyone with bipolar disorder, a history of mania, or a family history of bipolar disorder should only use methylfolate under close medical supervision. Screening for bipolar disorder before starting methylfolate supplementation for depression is recommended.
Is methylfolate the same as folate?
Methylfolate is one form of folate, but the terms are not interchangeable. 'Folate' is the umbrella term for vitamin B9, encompassing natural food folates and various supplemental forms. Methylfolate (L-5-methyltetrahydrofolate or 5-MTHF) is specifically the bioactive form that circulates in blood and participates in methylation reactions. Folic acid is synthetic and requires enzymatic conversion. Natural food folates exist as polyglutamates requiring digestion. Methylfolate is distinct because it bypasses the MTHFR conversion step required by folic acid, making it directly usable by the body without enzymatic processing.
Should I take methylfolate if I have MTHFR?
If you have confirmed MTHFR genetic variants (particularly C677T), methylfolate may be more appropriate than folic acid. The C677T polymorphism reduces MTHFR enzyme activity by 30-70%, impairing conversion of folic acid to its active form. Taking methylfolate bypasses this enzymatic bottleneck entirely, providing the bioactive form directly. Clinical trials in MTHFR polymorphism patients showed significant benefits including 30% homocysteine reduction. However, not everyone with MTHFR variants necessarily requires supplementation. Consider your homocysteine levels, symptoms, and overall health status. Consult with a healthcare provider who understands MTHFR to determine if methylfolate supplementation is appropriate for you.
Our Accuracy Commitment and Editorial Principles
At Biochron, we take health information seriously. Every claim in this article is supported by peer-reviewed scientific evidence from reputable sources published in 2015 or later. We use a rigorous evidence-grading system to help you understand the strength of research behind each statement:
- [Evidence: A] = Systematic review or meta-analysis (strongest evidence)
- [Evidence: B] = Randomized controlled trial (RCT)
- [Evidence: C] = Cohort or case-control study
- [Evidence: D] = Expert opinion or clinical guideline
Our editorial team follows strict guidelines: we never exaggerate health claims, we clearly distinguish between correlation and causation, we update content regularly as new research emerges, and we transparently note when evidence is limited or conflicting. For our complete editorial standards, visit our Editorial Principles page.
This article is for informational purposes only and does not constitute medical advice. Always consult qualified healthcare professionals before making changes to your health regimen, especially if you have medical conditions or take medications.
References
- 1 . Systematic Review and Meta-Analysis of L-Methylfolate Augmentation in Depressive Disorders, Pharmacopsychiatry, 2022, Volume 55, Issue 3, Pages 139-147. PubMed | DOI [Evidence: A]
- 2 . A Review of l-Methylfolate as Adjunctive Therapy in the Treatment of Major Depressive Disorder, The Primary Care Companion for CNS Disorders, 2023, Volume 25, Issue 3. PubMed | DOI [Evidence: D]
- 3 . Folate as adjunct therapy to SSRI/SNRI for major depressive disorder: Systematic review & meta-analysis, Complementary Therapies in Medicine, 2021, Volume 61, Article 102770. PubMed | DOI [Evidence: A]
- 4 . Folic Acid Supplementation and the Risk of Cardiovascular Diseases: A Meta-Analysis of Randomized Controlled Trials, Journal of the American Heart Association, 2016, Volume 5, Issue 8. PubMed | DOI [Evidence: A]
- 5 . Effect of Methylfolate, Pyridoxal-5′-Phosphate, and Methylcobalamin Supplementation on Homocysteine and LDL-C in MTHFR/MTR/MTRR Polymorphism Patients: A Randomized Controlled Trial, Nutrients, 2024, Volume 16, Issue 11. PubMed | DOI [Evidence: B]
- 6 . Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases, European Journal of Medical Genetics, 2015, Volume 58, Issue 1, Pages 1-10. PubMed | DOI [Evidence: D]
- 7 . The effects of folinic acid and l-methylfolate supplementation on serum total homocysteine levels in healthy adults, Clinical Nutrition ESPEN, 2023, Volume 58, Pages 14-20. PubMed | DOI [Evidence: B]
- 8 . The potential use of folate and its derivatives in treating psychiatric disorders: A systematic review, Biomedicine & Pharmacotherapy, 2022, Volume 146, Article 112541. PubMed | DOI [Evidence: A]
- 9 . Nutritional management of patients with diabetic peripheral neuropathy with L-methylfolate-methylcobalamin-pyridoxal-5-phosphate: results of a real-world patient experience trial, Current Medical Research and Opinion, 2016, Volume 32, Issue 2, Pages 219-227. PubMed | DOI [Evidence: C]
- 10 . Folate Supplementation for Peripheral Neuropathy: A Systematic Review, Nutrients, 2025, Volume 17, Issue 20. PubMed | DOI [Evidence: A]
- 11 . Folic Acid Supplementation to Prevent Neural Tube Defects: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force, JAMA, 2023, Volume 330, Issue 5, Pages 460-466. PubMed | DOI [Evidence: A]
- 12 . Efficacy of folic acid supplementation in the prevention of cardiovascular disease - a systematic review and meta-analysis of randomized controlled trials, BMC Nutrition, 2025, Volume 11, Issue 1, Article 203. PubMed | DOI [Evidence: A]
- 13 . Active Folate Versus Folic Acid: The Role of 5-MTHF (Methylfolate) in Human Health, Integrative Medicine (Encinitas), 2022, Volume 21, Issue 3, Pages 36-41. PubMed [Evidence: D]
- 14 . Conversion of calcium-l-methylfolate and (6S)-5-methyltetrahydrofolic acid glucosamine salt into dietary folate equivalents, EFSA Journal, 2022, Volume 20, Issue 8, Article e07452. PubMed | DOI [Evidence: D]
- 15 . The pharmacokinetic advantage of 5-methyltetrahydrofolate for minimization of the risk for birth defects, Scientific Reports, 2018, Volume 8, Issue 1, Article 4096. PubMed | DOI [Evidence: B]
- 16 . The Bioavailability of Various Oral Forms of Folate Supplementation in Healthy Populations and Animal Models: A Systematic Review, Journal of Alternative and Complementary Medicine, 2019, Volume 25, Issue 2, Pages 169-180. PubMed | DOI [Evidence: A]
Medical Disclaimer
This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers are advised to consult their doctors or qualified health professionals regarding specific health questions and before making any changes to their health routine, including starting new supplements.
Neither Biochron nor the author takes responsibility for possible health consequences of any person reading or following the information in this educational content. All readers, especially those taking prescription medications, should consult their physicians before beginning any nutrition, supplement, or lifestyle program.
If you have a medical emergency, call your doctor or emergency services immediately.